NeuroOne Medical Technologies Corporation (NMTC)
NMTC moved a median of -0.19% 30 minutes after news, and -0.54% by the close. How NMTC actually reacts to news — the realized, point-in-time move the market made, measured across 310 labeled events over the last three years with zero look-ahead.
NMTC’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 45% | 266 |
| 30-min | -0.19% | 41% | 305 |
| 60-min | -0.46% | 42% | 309 |
| to close | -0.54% | 43% | 310 |
| Middle 50% of NMTC reactions | -2.11% to +1.35% |
|---|---|
| Median reaction (30-min) | -0.19% |
| Measured reactions | 310 |
Half of all NeuroOne Medical Technologies Corporation news events land between -2.11% and +1.35% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when NMTC moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to NMTC's baseline. Nothing else.
Recent NMTC events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology | Press release | GlobeNewswire | -2.34% | +4.67% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Oct 05 | SEC filing · Form 8-K | SEC EDGAR | +8.90% | -5.51% | |
| NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order | Press release | GlobeNewswire | +8.90% | -5.51% | |
| NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement | Press release | GlobeNewswire | -0.18% | -8.11% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Aug 27 | SEC filing · Form 8-K | SEC EDGAR | +46.30% | -8.33% | |
| Form 10-Q NEUROONE MEDICAL TECHNOL For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.66% | +21.19% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | +0.66% | +21.19% | |
| Form 10-Q/A NEUROONE MEDICAL TECHNOL For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -2.63% | -2.92% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Jun 12 | SEC filing · Form 8-K | SEC EDGAR | -2.63% | -2.92% | |
| Form SD NEUROONE MEDICAL TECHNOL | SEC filing · Form SD | SEC EDGAR | -1.64% | +3.91% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: May 21 | SEC filing · Form 8-K | SEC EDGAR | +1.49% | +4.88% | |
| Form 10-Q NEUROONE MEDICAL TECHNOL For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +2.57% | +2.57% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: May 12 | SEC filing · Form 8-K | SEC EDGAR | +2.57% | +2.57% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Apr 30 | SEC filing · Form 8-K | SEC EDGAR | +4.31% | +1.13% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Apr 24 | SEC filing · Form 8-K | SEC EDGAR | +1.50% | +0.43% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Apr 14 | SEC filing · Form 8-K | SEC EDGAR | +2.06% | +0.00% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Apr 03 | SEC filing · Form 8-K | SEC EDGAR | +0.01% | +6.40% | |
| Form ARS NEUROONE MEDICAL TECHNOL For: Sep 30 | SEC filing · Form ARS | SEC EDGAR | +3.17% | -3.84% | |
| Form DEF 14A NEUROONE MEDICAL TECHNOL For: Apr 03 | SEC filing · Form DEF | SEC EDGAR | +3.17% | -3.84% | |
| Form PRE 14A NEUROONE MEDICAL TECHNOL For: Apr 03 | SEC filing · Form PRE | SEC EDGAR | +0.39% | -0.04% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Feb 25 | SEC filing · Form 8-K | SEC EDGAR | -2.61% | -5.28% | |
| Form 10-Q NEUROONE MEDICAL TECHNOL For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | -8.98% | -20.12% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Feb 17 | SEC filing · Form 8-K | SEC EDGAR | -8.98% | -20.12% | |
| Form 10-K/A NEUROONE MEDICAL TECHNOL For: Sep 30 | SEC filing · Form 10-K | SEC EDGAR | -0.92% | +2.17% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Dec 18 | SEC filing · Form 8-K | SEC EDGAR | +1.33% | +7.19% | |
| Form S-8 NEUROONE MEDICAL TECHNOL | SEC filing · Form S-8 | SEC EDGAR | +1.33% | +7.19% | |
| Form 10-K NEUROONE MEDICAL TECHNOL For: Sep 30 | SEC filing · Form 10-K | SEC EDGAR | +3.29% | -5.92% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Dec 17 | SEC filing · Form 8-K | SEC EDGAR | +3.29% | -5.92% | |
| Form SD NEUROONE MEDICAL TECHNOL | SEC filing · Form SD | SEC EDGAR | +3.29% | -5.92% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Nov 04 | SEC filing · Form 8-K | SEC EDGAR | -1.99% | -1.11% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Oct 06 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.85% | |
| NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025 | Press release | GlobeNewswire | +1.89% | +1.18% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Aug 18 | SEC filing · Form 8-K | SEC EDGAR | -8.16% | -15.31% | |
| NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain | Press release | GlobeNewswire | -8.16% | -15.31% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Aug 15 | SEC filing · Form 8-K | SEC EDGAR | -8.16% | -15.31% | |
| Form 10-Q NEUROONE MEDICAL TECHNOL For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.14% | -5.68% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | +1.14% | -5.68% | |
| NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9% | Press release | GlobeNewswire | +1.14% | -5.68% | |
| NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time | Press release | GlobeNewswire | -2.17% | -5.77% | |
| NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update | Press release | GlobeNewswire | -1.16% | -3.38% | |
| NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office | Press release | GlobeNewswire | -5.87% | -13.62% | |
| NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System | Press release | GlobeNewswire | -0.38% | +0.65% | |
| NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary | Press release | GlobeNewswire | -0.94% | -3.98% | |
| NeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025 | Press release | GlobeNewswire | — | -0.42% | |
| Form 10-Q NEUROONE MEDICAL TECHNOL For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.63% | -0.91% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: May 13 | SEC filing · Form 8-K | SEC EDGAR | +0.63% | -0.91% | |
| NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6% | Press release | GlobeNewswire | +0.63% | -0.91% | |
| NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor | Press release | GlobeNewswire | +3.27% | +0.45% | |
| Form 8-K NEUROONE MEDICAL TECHNOL For: May 06 | SEC filing · Form 8-K | SEC EDGAR | +3.27% | +0.45% | |
| NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time | Press release | GlobeNewswire | -0.94% | -2.85% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the NMTC section they belong to.
Where else NMTC is measured.
NMTC earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Dynavax Technologies Corporation (DVAX) | 310 | +0.07% | 56% |
| National HealthCare Corporation (NHC) | 310 | 0.00% | 49% |
| SI-BONE, Inc. (SIBN) | 310 | +0.14% | 56% |
| Galectin Therapeutics Inc. (GALT) | 309 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is NeuroOne Medical Technologies Corporation's median reaction calculated?
Every labeled NMTC news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 310 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 41% of NMTC's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does NMTC's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.